49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details
臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02307643 (ClinicalTrials.gov) | February 2015 | 18/11/2014 | Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients | An Exploratory Study of MT-1303 in Subjects With Systemic Lupus Erythematosus (a Multicenter, Open-label Study) | Systemic Lupus Erythematosus | Drug: MT-1303 Low dose;Drug: MT-1303 High dose | Mitsubishi Tanabe Pharma Corporation | NULL | Completed | 20 Years | 64 Years | All | 17 | Phase 1 | Japan |